Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on <i>N</i>-Glycosylation

• Main Authors: Steffen Meurer, Almut Elisabeth Wimmer, Eddy van de Leur, Ralf Weiskirchen
• Format: Article
• Language: English
• Published: MDPI AG 2019-08-01
• Series: Cells
• Subjects: exosomes; lipid raft; Caveolin-1; endoglin; BMP; TGF-β; liver; hepatic stellate cells; hepatocytes; portal myofibroblasts; shedding; fibrosis
• Online Access: https://www.mdpi.com/2073-4409/8/9/997

Injury of the liver involves a wound healing partial reaction governed by hepatic stellate cells and portal fibroblasts. Individual members of the transforming growth factor-&#946; (TGF-&#946;) superfamily including TGF-&#946; itself and bone morphogenetic proteins (BMP) exert diverse and partially opposing effects on pro-fibrogenic responses. Signaling by these ligands is mediated through binding to membrane integral receptors type I/type II. Binding and the outcome of signaling is critically modulated by Endoglin (Eng), a type III co-receptor. In order to learn more about trafficking of Eng in liver cells, we investigated the membranal subdomain localization of full-length (FL)-Eng. We could show that FL-Eng is enriched in Caveolin-1-containing sucrose gradient fractions. Since lipid rafts contribute to the pool of exosomes, we could consequently demonstrate for the first time that exosomes isolated from cultured primary hepatic stellate cells and its derivatives contain Eng. Moreover, via adenoviral overexpression, we demonstrate that all liver cells have the capacity to direct Eng to exosomes, irrespectively whether they express endogenous Eng or not. Finally, we demonstrate that block of <i>N</i>-glycosylation does not interfere with dimerization of the receptor, but abrogates the secretion of soluble Eng (sol-Eng) and prevents exosomal targeting of FL-Eng.